J&J Acquires Halda Therapeutics for $3.05 Billion — A Big Push in Cancer Treatment
Johnson & Johnson (J&J) has signed a $3.05 billion all-cash agreement to acquire Halda Therapeutics, a U.S.-based clinical-stage…
Johnson & Johnson (J&J) has signed a $3.05 billion all-cash agreement to acquire Halda Therapeutics, a U.S.-based clinical-stage…